Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6302 of 6351
-
Can the 'Love Hormone' ease pain? small study tests oxytocin
Knowledge-focused Stopped earlyThis is a study of participants that will receive an intravenous (IV) infusion of oxytocin (naturally occurring hormone that is made in the brain). In this study healthy volunteers and people with knee arthritis so severe that they may need joint replacement are recruited for a …
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:39 UTC
-
COVID-19 drug trial pulled before it started
Disease control CancelledThis is a randomized controlled trial to evaluate the efficacy and safety of itolizumab in subjects hospitalized with COVID-19.
Phase 3 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Phone calls from nurses aim to tame high blood pressure in women
Disease control Stopped earlyThis study evaluate the feasibility of a 6-month personalized support program for hypertensive and non-observant women, led by nurses by telephone follow-up.
Sponsor: Mme Edith DAUCHY • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Healthy volunteers help uncover drug interactions for KBP-5074
Knowledge-focused CompletedOpen-label, parallel, 2-arm, fixed-sequence study to investigate the effect of coadministration of a CYP3A4 inhibitor (Cohort 1, itraconazole multiple dose) and CYP3A4 inducer (Cohort 2, rifampin multiple dose) on the plasma PK of a single dose of KBP-5074 in healthy male and fem…
Phase 1 • Sponsor: KBP Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New drug LY3522348 put to the test in healthy volunteers
Knowledge-focused CompletedThe main purpose of this study in healthy participants is to learn more about the safety of LY3522348 and any side effects that might be associated with it. Blood tests will be performed to check how much LY3522348 gets into the bloodstream and how long it takes the body to elimi…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Biosimilar allergy drug trial halted after just one volunteer
Knowledge-focused Stopped earlyTo evaluate the bioequivalence of HS632 and Omalizumab (Xolair®) in a single subcutaneous administration in healthy subjects.
Phase 1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Nerve pain device study abandoned after only 2 patients
Symptom relief Stopped earlyThe objective of this study is to capture the change in pain intensity, physical/emotional function, and pain impact for patients diagnosed with neuropathic pain who undergo an Exablate treatment.
Sponsor: InSightec • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
PRP wrist study pulled before it even started
Symptom relief CancelledPlatelet-rich Plasma (PRP) is formed when a patient's blood sample is concentrated by a commercially available centrifuge. The sample then contains a high concentration of growth factors and has been used for numerous indications in a number of joints. This process has not yet be…
Sponsor: Edna Rath • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Pain study pulled before it even started
Knowledge-focused CancelledThe ALGOBASES project is an observational epidemiological study of pain through the collection of pain evaluation questionnaires and information with the aim of creating a descriptive "pain" evaluation in all patients who need to benefit from orthopedic, thoracic or gynecological…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Leishmaniasis drug candidate tested in humans for first time – study halted early
Knowledge-focused Stopped earlyThis study is the first to test GSK3494245 in humans, to evaluate its safety, tolerability, and pharmacokinetics (PK) after a single dose. It involves 3 groups of participants and has a crossover design where each participant received a maximum of 3 ascending oral doses of GSK349…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Tiny bone marker study in myeloma ends early
Knowledge-focused Stopped earlyThe aim of this study is looking at the Kinetics of bone turnover markers (C-terminal telopeptides of type I collagene (CTX), amino-terminal telopeptide of type 1 collagen (NTX), Dickkopf-1 (DKK-1) and Sclerostin (SOST)) in serum and urine until 12 months in Patients with Multipl…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
HIV herbal pill trial pulled before a single patient enrolled
Disease control CancelledThis is a plant-based medication used to increase the amount, protect, and reduce HIV's impact on T and B lymphocytes.
Phase 4 • Sponsor: Trieu, Nguyen Thi, M.D. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Malaria prevention study pulled before it began
Prevention CancelledThis study assesses the effectiveness and feasibility of enhanced reactive case detection (RACD) targeting high-risk villages and forest workers for reducing Plasmodium falciparum and Plasmodium vivax transmission in southern Lao Peoples Democratic Republic. The authors hypothesi…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Chewing gum vs. mouthwash: which keeps your mouth cleaner all day?
Symptom relief CompletedThe goal of this clinical trial is to test if the additional use of different commercially available products for a better breath and plaque reduction, taken during daytime between morning and evening tooth brushing, can reduce the plaque formation of participants during the day.…
Sponsor: King Abdullah University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
COVID-19 ICU Follow-Up study pulled before starting
Knowledge-focused CancelledSome patients admitted to intensive care for a severe form of COVID-19 could have respiratory, cardiac, renal and neurological sequelae in the medium or long term. The results of this research will allow an improvement in the understanding and management of patients in the mediu…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC
-
Could a High-Tech vest replace wires after surgery?
Knowledge-focused CompletedThe objective of this study is to evaluate an experience of post-operative monitoring using the Nanowear wearable multiple sensor vest in plastic surgery
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Cookie power! study tests if a healthy treat can supercharge your cells
Knowledge-focused OngoingThe proposed research is an intervention and feasibility pilot trial designed to determine if short-term consumption of healthy cookies made with an oil rich in linoleic acid can influence mitochondria biology in white blood cells and muscle. The hypothesis of the study is that c…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Fat grafting study for bedsores pulled before it began
Prevention CancelledAutografting of fat cells is widely used in plastic surgery in breast reconstruction, burn scars, unsightly scars etc. It is known that the autografting of fat cells not only makes it possible to bring adipocytes, and thus to create a volume, but also promotes neo-angiogenesis by…
Sponsor: Rennes University Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Opioid safety app study pulled before it began
Knowledge-focused CancelledA key driver of the current opioid overdose epidemic is the misuse of legitimately prescribed opioid medications. Patient education through use of mobile technology may help to increase knowledge of appropriate use of opioid medications; however, knowledge does not always transla…
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Scientists investigate hidden chemical pathways in healthy volunteers
Knowledge-focused By invitation onlyProstaglandins are important signaling compounds formed from arachidonic acid. The enzymes that form prostaglandins, cyclooxygenase-1 and -2 are the targets of non-steroidal anti-inflammatory drugs (NSAIDs). Because prostaglandins are very unstable in the body, they can not be me…
Early phase 1 • Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC